Home
>
US Stocks
>
Accelerate Diagnostics Inc
Accelerate Diagnostics Inc
AXDX

Accelerate Diagnostics Inc (AXDX)

$6.6910.4%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.8
Today Low/High
6.61 / 6.8
52 Week Low/High
$5.76 / $15.74
Market Cap
$381.91M

Company Details

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
Organisation
Accelerate Diagnostics Inc
Headquaters
Tucson, Arizona, US
Employees
224
Industry
Health Technology
CEO
John Phillips

Discover more

Frequently Asked Questions

What is Accelerate Diagnostics Inc (AXDX) share price today?

Can Indians buy Accelerate Diagnostics Inc (AXDX) shares?

How can I buy Accelerate Diagnostics Inc (AXDX) shares from India?

Can Fractional shares of Accelerate Diagnostics Inc (AXDX) be purchased?

What are the documents required to start investing in Accelerate Diagnostics Inc (AXDX) stocks?

We are a SEBI registered investement advisor